Muhammad Farhan is a PhD student in the BNCT program at THE HADRON ACADEMY: Risk and Complexity in High-Tech Medical Innovation at CNAO, Italy. Originally from Pakistan, he holds a master’s degree in Biophysics, where he conducted extensive research on magnetic nanoparticles for targeted drug delivery, cancer treatment, hyperthermia, and gene delivery. His work involved synthesizing and characterizing nanoparticles to enhance their biomedical applications, particularly in oncology.
Now, he is focusing on Boron Neutron Capture Therapy (BNCT), an advanced cancer treatment that utilizes boron-containing compounds and neutron irradiation to selectively destroy malignant cells while minimizing damage to healthy tissue. This innovative approach integrates nuclear physics and medical science, offering a promising alternative for treating aggressive and resistant tumors.
Farhan’s academic journey bridges physics, nanomedicine, and radiotherapy, reflecting his commitment to advancing medical technologies. His research aims to refine BNCT methodologies, improve treatment precision, and contribute to the development of next-generation cancer therapies. Through his work, he seeks to make meaningful contributions to high-tech medical innovations that enhance patient care and therapeutic outcomes.